Presentation is loading. Please wait.

Presentation is loading. Please wait.

IST3 Perfusion and Angiography Study Collaborators Meeting ESC 2010, Barcelona, May 27 th 2010.

Similar presentations


Presentation on theme: "IST3 Perfusion and Angiography Study Collaborators Meeting ESC 2010, Barcelona, May 27 th 2010."— Presentation transcript:

1 IST3 Perfusion and Angiography Study Collaborators Meeting ESC 2010, Barcelona, May 27 th 2010

2 Background Perfusion and angiography imaging used increasingly in acute stroke Radiation dose Problems with renal function and diabetes Delays treatment Wide variation in terminology and definitions Uncertainty about processing and interpretation

3 NEJM 2009;361:849-57 : Survey of 952,420 adults, USA: Mean 2.4 mSv  1 CT brain scan per year Medium to high doses in 2% and 0.2% respectively (ie at or above max permitted for radiation worker) New York Times 15 th Oct 2009 Cedars-Sinai Medical Center, …… had mistakenly given up to eight times the normal radiation dose to 206 possible stroke victims..involvedstroke CT brain perfusion scans. Cedars-Sinai began investigating the procedure in August after a patient noted a “temporary patchy hair loss.”hair loss CT radiation exposure

4 Radiation Doses: CT, CT angiography, CT perfusion ProcedureDose background ( mSv) radiation equiv. (years) CT brain 1.8 1.0 CT angio 2.2 1.5-2.0 CT perfusion 3-5 1.5-2.5 2x CT, CTA, CTP 22 9 Better evidence required to show that benefits outweigh risks, costs, time

5 Aims 1. Do acute ischaemic stroke patients with imagevidence of tissue at risk (mismatch) on either CT with CTP or MR DWI/PWI, have a) less infarct growth and b) better functional outcome if treated with rt-PA than do patients without mismatch? 2. Which perfusion parameter (CBF, CBV, MTT or some derivative), processing method (qualitative, quantitative) and threshold best predicts: a) infarct growth at 24 hours and b) poor functional outcome at six months? 3. Can we clarify imaging features on plain CT or MR DWI that differentiate viable from non-viable tissue?

6 Progress Funding NIHR EME 2009-2012 Protocol Image acquisition guidance Image processing established + piloted Recruitment Questions to be resolved

7 Imaging Parameters Guide Line Perfusion Acquisition Parameters –Based on experience in current studies Compatible with STIR recommendation –Acute Stroke Imaging Research Roadmap. Stroke, 2008; 39: 1621 – 1628 –3 key points – CT perfusion 80 kvp for the perfusion Start Imaging soon enough –Be careful of delay time between injection and acquisition Image for long enough –Capture full signal time curve - CT – non contrast whole brain volume needed – please send as well

8 Imaging Parameters – rationale and common errors MR DataStart (Time) Finish (Time) Injection16.0- AIF2748 White Matter 3353 Delay required to reduce dose At least 1 pre-contrast volume Must capture washout in white matter and infarct to construct adequate signal-time curve Commonest errors: To long a delay between contrast and acquisition Not imaging for long enough

9 Data processing Datasets submitted by normal IST3 routes Guideline acquisition parameters available Please remember to submit CT volume scan as well –Perfusion and Angiography processed separately –Centralised processing Catalogued Quality Assured Processed –PMA, ASIST Analysed Angiography read according to TIMI and MORI scores

10 Perfusion Analysis Construct perfusion image Register data sets between different time points to map lesion development –MR and CT have different resolution, field of view and slicing planes –Requires interpolation

11 IST-3 Perfusion and Angiography Perfusion analysis 1.Qualitative visual rating of perfusion lesion and mismatch extent IST-3 ASPECTS for all perfusion parameters including raw data 2. Quantitative tissue perfusion threshold analysis

12 Benefits of registering CT and MR at different time points – tissue measurements Pre-randomisationMR DWI image K Rowland, T Carpenter, J Wardlaw

13 Measure tissue change in CT attenuation 20 patients, mean age 75.5 ± 12.5 years; mean admission NIHSS 14 ± 7; mean time from stroke to CT 174 mins (range 75-330). All differences ischaemic:contralateral tissue p  0.01

14 IST-3 Perfusion and Angiography Perfusion Parameters to be tested MR perfusionCT perfusion Raw data rCBF rCBV rMTT (first moment)rMTT (1.45 wrt normal side) TTP (various thresholds)TTP (1.4 wrt normal side) Tmax +2 s as per EPITHET Tmax + 4 s as per EPITHET ATF CBFqCBFq (including 12.7 mL/100 g/min) CBVqCBVq (including < 2.2 mL/100g) MTTq

15 IST-3 Perfusion and Angiography Perfusion Parameters to be tested ARE THERE ANY OTHER PARAMETERS THAT SHOULD BE TESTED???

16 IST-3 Perfusion and Angiography Perfusion Parameters to be tested MR perfusionCT perfusion Raw data rCBF rCBV rMTT (first moment)rMTT (1.45 wrt normal side) TTP (various thresholds)TTP (1.4 wrt normal side) Tmax +2 s as per EPITHET Tmax + 4 s as per EPITHET ATF CBFqCBFq (including 12.7 mL/100 g/min) CBVqCBVq (including < 2.2 mL/100g) MTTq

17 IST-3 Perfusion and Angiography Study Recruitment – 12 th May 2010 CT Perfusion 63 MR Perfusion 29 CT Angiography 102 MR Angiography 97 CTMR Perfusion Randomisation 5518 Perfusion Post Randomisation 39 Angiography Randomisation 7623 Angiography Post Randomisation 948 Strong preference for CT pre-randomisation, MR at follow up.

18 Target sample estimate 60% will have mismatch overall; 70% with mismatch will have infarct growth vs. 30% without mismatch; rt-PA will reduce infarct growth by 20% in those with, but not those without mismatch. Difference in infarct growth detectable, + vs - rt-PA, + vs - mismatch (80% power, alpha of 0.05): Ndifference in infarct growth 100 27% 160 20% 400 15% We acknowledge that, with at most 300 patients, we may not detect a “rt-PA x mismatch effect”

19 TARGET SAMPLE Pre-randomisation so far: 73 perfusion 99 angiography Rate: Last year 0.8 per week Current 1.2 per week Potential by mid 2011: 150 - 200 patients, possibly as many as 300

20 Ways to encourage recruitment Encourage sending of data Collaborator meeting IST3 Perfusion and Angiography Study

21 Thank you

22

23 Perfusion analysis – obstacles CT to MR registration artefact Change of resolution (MR registered to CT)

24 Perfusion analysis – obstacles CT to MR registration artefact Change of slicing plane CTP registered to MRP CT volume

25 Solution: ROI transformation Perform registration as normal Draw ROI on original image Apply transform to ROI –Requires shape based interpolation Change of slicing plane

26 Down Sampling Change of resolution (MR registered to CT)

27 Down Sampling Change of resolution (MR registered to CT)

28 ROI transformation Change of slicing plane MR Registered to MRP CT


Download ppt "IST3 Perfusion and Angiography Study Collaborators Meeting ESC 2010, Barcelona, May 27 th 2010."

Similar presentations


Ads by Google